Clinical Trial Update: Biorest Liposomal Alendronate With Stenting sTudy (BLAST) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Biorest's liposomal alendronate with stenting (BLAST) in coronary artery stenosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis

Drugs mentioned

• Biorest Liposomal Alendronate (liposomal alendronate)

Snippet

Sponsor: BIOrest Ltd. | Conditions: Coronary Artery Stenosis | Phase 2 | Status: COMPLETED